| Stage | CHRW | % of rev | RLGT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.4B | 100.00% | $214M | 100.00% | CHRW ×25.02 |
| Gross profit | $448M | 8.36% | $35M | 16.27% | RLGT +7.9pp |
| Operating income | $272M | 5.07% | $7M | 3.06% | CHRW +2.0pp |
| Pre-tax income | $250M | 4.67% | $6M | 3.01% | CHRW +1.7pp |
| Net income | $198M | 3.70% | $5M | 2.13% | CHRW +1.6pp |
| Stage | CHRW | RLGT | Gap · A − B |
|---|---|---|---|
| Revenue | $5.4B100.00% | $214M100.00% | CHRW ×25.02 |
| Gross profit | 8.36%$448M | 16.27%$35M | RLGT +7.9pp |
| Operating income | 5.07%$272M | 3.06%$7M | CHRW +2.0pp |
| Pre-tax income | 4.67%$250M | 3.01%$6M | CHRW +1.7pp |
| Net income |
| 3.70%$198M |
| 2.13%$5M |
| CHRW +1.6pp |
No disclosed counterparties: CHRW, RLGT.